The extent and severity of vascular leakage as evidence of tumor aggressiveness in high-grade gliomas

被引:54
作者
Cao, Yue
Nagesh, Vijaya
Hamstra, Daniel
Tsien, Christina I.
Ross, Brian D.
Chenevert, Thomas L.
Junck, Larry
Lawrence, Theodore S.
机构
[1] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA
关键词
D O I
10.1158/0008-5472.CAN-05-4328
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Magnetic resonance imaging reveals heterogeneous regions within high-grade gliomas, such as a contrast-enhanced rim, a necrotic core, and non-contrast-enhanced abnormalities. It is unclear which of these regions best describes tumor aggressiveness. We hypothesized that the vascular leakage volume, reflecting disorganized angiogenesis typical of glioblastoma, would be a strong predictor of clinical outcome. The FLAIR tumor volume, post-gadolinium T1 tumor volume, tumor vascular leakage volume determined by dynamic contrast-enhanced imaging, and volume of the contrast-enhanced rim seen on post-gadolinium T1-weighted images were defined for 20 patients about to undergo treatment for newly diagnosed high-grade gliomas. The potential for imaging characteristics to improve prediction of survival and time to progression over clinical variables was tested by using Cox regression analysis. Single-variable Cox regression analysis of each of the four tumor subvolurnes revealed that the vascular leakage volume was the only significant predictor of survival. When the joint effect of clinical variables and the vascular leakage volume were tested for prediction of survival, only the age and the vascular leakage volume were selected as significant predictors. However, when time to progression was tested as a dependent variable, both the vascular leakage volume and the vascular permeability were selected as copredictors, along with surgical status. Our findings suggest that for patients with high-grade glioma, time to progression after radiation therapy is influenced by both underlying biological aggressiveness (vascularity) and volume of aggressive tumor. In contrast, survival depends chiefly on the volume of aggressive tumor at the time of presentation.
引用
收藏
页码:8912 / 8917
页数:6
相关论文
共 16 条
[1]   MIGRATION AND PROLIFERATION OF ENDOTHELIAL CELLS IN PREFORMED AND NEWLY FORMED BLOOD-VESSELS DURING TUMOR ANGIOGENESIS [J].
AUSPRUNK, DH ;
FOLKMAN, J .
MICROVASCULAR RESEARCH, 1977, 14 (01) :53-65
[2]  
Brem S, 1976, Clin Neurosurg, V23, P440
[3]   Physiologic and metabolic magnetic resonance imaging in gliomas [J].
Cao, Y ;
Sundgren, PC ;
Tsien, CI ;
Chenevert, TT ;
Junck, L .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (08) :1228-1235
[4]   Estimate of vascular permeability and cerebral blood volume using Gd-DTPA contrast enhancement and dynamic T2*-weighted MRI [J].
Cao, Yue ;
Shen, Zhen ;
Chenevert, Thomas L. ;
Ewing, James R. .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2006, 24 (02) :288-296
[5]  
Graves EE, 2001, AM J NEURORADIOL, V22, P613
[6]   A preliminary study of the prognostic value of proton magnetic resonance spectroscopic imaging in gamma knife radiosurgery of recurrent malignant gliomas [J].
Graves, EE ;
Nelson, SJ ;
Vigneron, DB ;
Chin, C ;
Verhey, L ;
McDermott, M ;
Larson, D ;
Sneed, PK ;
Chang, S ;
Prados, MD ;
Lamborn, K ;
Dillon, WP .
NEUROSURGERY, 2000, 46 (02) :319-326
[7]   L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy [J].
Grosu, AL ;
Weber, WA ;
Riedel, E ;
Jeremic, B ;
Nieder, C ;
Franz, M ;
Gumprecht, H ;
Jaeger, R ;
Schwaiger, M ;
Molls, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (01) :64-74
[8]   Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF [J].
Holash, J ;
Maisonpierre, PC ;
Compton, D ;
Boland, P ;
Alexander, CR ;
Zagzag, D ;
Yancopoulos, GD ;
Wiegand, SJ .
SCIENCE, 1999, 284 (5422) :1994-1998
[9]   New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF [J].
Holash, J ;
Wiegand, SJ ;
Yancopoulos, GD .
ONCOGENE, 1999, 18 (38) :5356-5362
[10]   Measuring blood volume and vascular transfer constant from dynamic, T*2-weighted contrast-enhanced MRI [J].
Johnson, G ;
Wetzel, SG ;
Cha, S ;
Babb, J ;
Tofts, PS .
MAGNETIC RESONANCE IN MEDICINE, 2004, 51 (05) :961-968